MarketCapTrends
IART

Integra LifeSciences Holdings Corporation (IART)

NASDAQ · Healthcare

Integra LifeSciences Holdings Corporation annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Integra LifeSciences Holdings Corporation total liabilities for the quarter ending December 31, 2025 were 2.56B, a 2.66% increase year-over-year.
  • Integra LifeSciences Holdings Corporation total liabilities for 2025 were 2.56B, a 2.66% increase from 2024.
  • Integra LifeSciences Holdings Corporation total liabilities for 2024 were 2.49B, a 13.58% increase from 2023.
  • Integra LifeSciences Holdings Corporation total liabilities for 2023 were 2.19B, a 5.21% increase from 2022.
  • Integra LifeSciences Holdings Corporation total liabilities for 2022 were 2.09B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Integra LifeSciences Holdings Corporation Annual Total Liabilities (Millions of US $)
2025$2,559
2024$2,492
2023$2,194
2022$2,085
2021$2,098
2020$2,100
2019$1,887
2018$1,732
2017$2,249
2016$968
Integra LifeSciences Holdings Corporation Quarterly Total Liabilities (Millions of US $)
2025-12-31$2,559
2024-12-31$2,492
2023-12-31$2,194
2022-12-31$2,085
2021-12-31$2,098
2020-12-31$2,100
2019-12-31$1,887
2018-12-31$1,732
2017-12-31$2,249
2016-12-31$968

Integra LifeSciences Holdings Corporation Total Liabilities — FAQ

Integra LifeSciences Holdings Corporation (IART) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see IART's total liabilities history?

The chart and table above show Integra LifeSciences Holdings Corporation's total liabilities by year and by quarter, including the growth rate.